Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
151
NMPA:151
Drug Approvals
Epinephrine Hydrochloride Injection
- Product Name
- 盐酸肾上腺素注射液
- Approval Number
- 国药准字H20254338
- Approval Date
- May 27, 2025
NMPA
Metaraminol Bitartrate Injection
- Product Name
- 重酒石酸间羟胺注射液
- Approval Number
- 国药准字H20254183
- Approval Date
- May 13, 2025
NMPA
Norepinephrine Bitartrate Injection
- Product Name
- 重酒石酸去甲肾上腺素注射液
- Approval Number
- 国药准字H20249676
- Approval Date
- Dec 1, 2024
NMPA
Dopamine Hydrochloride Injection
- Product Name
- 盐酸多巴胺注射液
- Approval Number
- 国药准字H20247250
- Approval Date
- Oct 23, 2024
NMPA
Dopamine Hydrochloride Injection
- Product Name
- 盐酸多巴胺注射液
- Approval Number
- 国药准字H20247249
- Approval Date
- Oct 23, 2024
NMPA
Dopamine Hydrochloride Injection
- Product Name
- 盐酸多巴胺注射液
- Approval Number
- 国药准字H20247126
- Approval Date
- Jun 12, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 16
- Next
Clinical Trials
No trials found
News
No news found